NCT06613854View on ClinicalTrials.gov

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
DRUG

Oral semaglutide

Semaglutide Oral Tablets will be introduced to the Oral Semaglutide Arm as per protocol for regular therapy introduction.

DRUG

Empagliflozin 10 mg

Empagliflozin Oral Tablets will be introduced to the Empagliflozin Arm as per protocol for regular therapy introduction.

Trial Locations (1)

1000

RECRUITING

University Medical Centre Ljubljana, Diabetes Outpatient Clinic, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER